| Biotechnology feed | All feeds
(King) is an integrated pharmaceutical company that develops, manufactures and markets therapies and technologies to the markets including neuroscience, hospital and acute care medicines. TradingMarkets: Mar 16 2010 11:05AM Matching: skelaxin Find similar documents
(KG), Pain Therapeutics, Inc.
(PTIE) King Pharmaceuticals, Inc.
(KG) reported fourth-quarter earnings of 23 cents per share, a penny below the Zacks Consensus Estimate.
Despite fourth quarter... Zibb: Feb 26 2010 1:09PM Matching: skelaxin Find similar documents
King, whose shares fell 2.6... FinanzNachrichten.de: Feb 25 2010 3:53PM Matching: skelaxin Find similar documents
said Thursday it earned $22.3 million in the fourth-quarter of 2009, reversing a loss a year ago that was largely tied to acquisition-related costs.
The Bristol, Tenn., company said it earned 9 cents per share in the... Bioscience Technology Online: Feb 25 2010 2:24PM Matching: skelaxin Find similar documents
Drug developer King Pharmaceuticals Inc.
The Bristol, Tenn., company said it earned 9 cents... DCExaminer.com: Feb 25 2010 1:44PM Matching: skelaxin Find similar documents
King posted fourth-quarter net... Interactive Investor: Feb 25 2010 1:07PM Matching: skelaxin Find similar documents
King posted fourth-quarter net... FinanzNachrichten.de: Feb 25 2010 12:51PM Matching: skelaxin Find similar documents
Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.
All rights reserved. All other trademarks recognized. Copyright 1997-2009 - BioPortfolio Limited.
